Mass spectrometry based biomarkers for early detection of HCC using a glycoproteomic approach
Yehia Mechref(Texas Tech University), David M. Lubman(University of Michigan), Parisa Ahmadi(Texas Tech University), Suyu Liu(The University of Texas MD Anderson Cancer Center), Neehar D. Parikh(University of Michigan), Sakshi Gautam(Texas Tech University), Jie Zhang(Yan'an University), Yu Lin(University of Michigan–Ann Arbor), Amit G. Singal(Southwestern Medical Center), Wenjing Peng(Texas Tech University), Jianhui Zhu(Qingdao University)
Cited by 8
Related Papers
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
|Hepatology|2023|1.6k
Comparison of the methods for profiling glycoprotein glycans—HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study
|Glycobiology|2007|396
O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease
|Nature Chemistry|2015|305
Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?
|The American Journal of Gastroenterology|2013|227
Racial, Social, and Clinical Determinants of Hepatocellular Carcinoma Surveillance
|The American Journal of Medicine|2014|177